department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Invivyd, Inc. ($IVVD) · pharmadog

PUBLIC COMPANY

$IVVDInvivyd, Inc.

New Haven, CT, USupdated 1mo ago

SEC EDGAR ↗Yahoo Finance ↗

community read0 votes

pipeline

2

marketed

1

phase 3

1

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(2)

pipeline depth2 products

1Phase 31Marketed

Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019 (COVID-19)

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Invivyd, Inc. jobs →

News

no news has mentioned this company yet

identifiers

ticker

$IVVD

SEC CIK

0001832038

country

US

source

sec_tickers

top tags

Infectious Disease2

mentioned in

0news items

entity-linker matched

$IVVD

Data sources

last refreshed 36m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Active trials

phase3Study of VYD2311 for the Prevention of COVID-19recruitingn=1,770
phase3A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2completedn=790
phase1A Study of the Investigational Monoclonal Antibody, VYD2311, in Healthy Participantsactive not recruitingn=40
phase3Evaluation of ADG20 for the Prevention of COVID-19terminatedn=2,582
—Provide Pre-approval Single-patient Expanded Access (Compassionate Use) of VYD222 for Patients With Symptomatic COVID-19 Refractory to Other Treatmentsno longer available
phase1A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of the Monoclonal Antibody VYD222 in Healthy Adult Participantscompletedn=30
phase3Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19terminatedn=399

Insider activity

source: SEC Form 4

open-market buys + sells

Feb 18, 26SELLAndersen Jill· Chief Legal Officer, Secretary34,939 sh @ $1.58−$55K↗
Feb 18, 26SELLGreen Julie· Chief Human Resources Officer20,964 sh @ $1.58−$33K↗
Feb 18, 26SELLDuke William E.· Chief Financial Officer20,964 sh @ $1.58−$33K↗
Feb 18, 26SELLLee Timothy Edward· Chief Commercial Officer20,964 sh @ $1.58−$33K↗
Feb 18, 26SELLAllen Robert D. III· Chief Scientific Officer19,392 sh @ $1.58−$31K↗
Feb 17, 26SELLAndersen Jill· Chief Legal Officer, Secretary32,771 sh @ $1.54−$50K↗
Feb 17, 26SELLGreen Julie· Chief Human Resources Officer19,663 sh @ $1.54−$30K↗
Feb 17, 26SELLDuke William E.· Chief Financial Officer19,663 sh @ $1.54−$30K↗
Feb 17, 26SELLLee Timothy Edward· Chief Commercial Officer19,663 sh @ $1.54−$30K↗
Feb 17, 26SELLAllen Robert D. III· Chief Scientific Officer18,189 sh @ $1.54−$28K↗

routine RSU / option mechanics (6)

Feb 15, 26option exerciseGreen Julie · Chief Human Resources Officer99,000 sh
Feb 15, 26option exerciseAllen Robert D. III · Chief Scientific Officer99,000 sh
Feb 15, 26option exerciseAllen Robert D. III · Chief Scientific Officer99,000 sh
Feb 15, 26option exerciseGreen Julie · Chief Human Resources Officer99,000 sh
Feb 15, 26option exerciseDuke William E. · Chief Financial Officer99,000 sh

Feb 15, 26

option exercise

Duke William E. · Chief Financial Officer

99,000 sh